Li et al. (120) used Ang II to induce the CHF model when studying the intervention effect of Shengmai injection on animals with chronic heart failure and discovered that Shengmai injection can reduce cardiomyocyte hypertrophy and apoptosis, protect mitochondrial function in hypertrophic cardiomyocytes, and inhibit cardiac fibrosis. This evidence concerns the gene AGT and congestive heart failure.